Fresenius Medical Care Ag ADR (FMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 517,926 | 358,522 | 143,678 | 942,261 | 705,788 |
| Depreciation Amortization | 1,443,259 | 950,834 | 469,950 | 1,936,899 | 1,353,365 |
| Income taxes - deferred | -97,429 | -63,827 | -24,015 | -43,694 | -60,513 |
| Accounts receivable | -82,757 | -30,559 | -383,041 | -49,184 | -43,231 |
| Accounts payable and accrued liabilities | -28,844 | -19,029 | -27,075 | -9,194 | -52,646 |
| Other Working Capital | 477,844 | 120,755 | -362,459 | -134,931 | -185,499 |
| Other Operating Activity | -151,443 | -62,761 | 336,282 | -358,606 | -138,256 |
| Operating Cash Flow | $2,078,556 | $1,253,937 | $153,319 | $2,283,551 | $1,579,008 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -467,566 | -322,581 | -150,805 | -724,648 | -489,297 |
| Net Acquisitions | 4,877 | 12,063 | 8,665 | 1,083 | 16,677 |
| Purchase Of Investment | -106,812 | -68,120 | -49,254 | -111,303 | -92,794 |
| Sale Of Investment | 82,196 | 55,200 | 16,133 | 60,762 | 51,964 |
| Investing Cash Flow | $-487,305 | $-323,437 | $-175,262 | $-774,106 | $-513,450 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 411,401 | 807,079 | 111,151 | 755,530 | 665,502 |
| Debt Issued | 229,181 | 10,374 | 6,947 | 1,039,821 | 1,034,077 |
| Debt Repayment | -38,310 | -26,603 | -15,235 | -784,532 | -766,978 |
| Common Stock Issued | N/A | N/A | N/A | 21,233 | 20,296 |
| Dividend Paid | -612,631 | -528,434 | -89,596 | -740,652 | -618,042 |
| Other Financing Activity | -1,200,895 | -1,026,291 | -11,105 | -1,995,452 | -1,843,082 |
| Financing Cash Flow | $-1,211,253 | $-763,874 | $2,162 | $-1,704,051 | $-1,508,226 |
| Exchange Rate Effect | -52,855 | -71,204 | -33,779 | -24,404 | 71,915 |
| Beginning Cash Position | 1,386,390 | 1,388,937 | 1,367,283 | 1,561,072 | 1,492,323 |
| End Cash Position | 1,713,532 | 1,484,359 | 1,313,724 | 1,342,062 | 1,121,570 |
| Net Cash Flow | $327,143 | $95,422 | $-53,559 | $-219,010 | $-370,753 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,078,556 | 1,253,937 | 153,319 | 2,283,551 | 1,579,008 |
| Capital Expenditure | -472,712 | -324,435 | -152,563 | -762,794 | -498,165 |
| Free Cash Flow | 1,605,844 | 929,502 | 756 | 1,520,757 | 1,080,843 |